BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 14172950)

  • 1. Monoamine effects on neuronal recovery cycles in globus pallidus, caudate nucleus, and substantia nigra.
    Dafny N; Gilman S
    J Neural Transm; 1974; 35(4):275-81. PubMed ID: 4612113
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity.
    Andén NE; Strömbom U
    Psychopharmacologia; 1974; 38(2):91-103. PubMed ID: 4533319
    [No Abstract]   [Full Text] [Related]  

  • 3. Motor disturbance induced by tremorine and oxotremorine.
    Jurna I; Nell T; Schreyer I
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 267(1):80-98. PubMed ID: 4393397
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of phenytoin and metamphetamine on spinal motor activity.
    Jurna I; Theres C
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(3):244-59. PubMed ID: 4243220
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of physostigmine and tetrabenazine on spinal motor control and its inhibition by drugs which influence reserpine rigidity.
    Jurna I; Theres C; Bachmann T
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(3):427-38. PubMed ID: 4239718
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity.
    Jurna I; Lanzer G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(3):309-24. PubMed ID: 4238719
    [No Abstract]   [Full Text] [Related]  

  • 7. The antagonism between reserpine and some antiparkinson drugs in electroseizure.
    Jurna I; Regélhy B
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(5):442-59. PubMed ID: 4236499
    [No Abstract]   [Full Text] [Related]  

  • 8. Depression by antiparkinson drugs of reserpine rigidity.
    Jurna I
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968 May; 260(1):80-8. PubMed ID: 4236376
    [No Abstract]   [Full Text] [Related]  

  • 9. Reserpine rigidity in the rat--a model for the analysis of antiparkinson drugs.
    Jurna I
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(2):181. PubMed ID: 4232669
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-induced extrapyramidal syndromes.
    Lader MH
    J R Coll Physicians Lond; 1970 Oct; 5(1):87-98. PubMed ID: 4150143
    [No Abstract]   [Full Text] [Related]  

  • 11. Lisuride, a potent drug in the treatment of muscular rigisity in rats.
    Loos D; Halbhübner K; Herken H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Nov; 300(2):195-8. PubMed ID: 593443
    [No Abstract]   [Full Text] [Related]  

  • 12. [EXPERIMENTAL ANTAGONISM OF CHLORPROMAZINE AND THIORIDAZINE IN RELATION TO CERTAIN EFFECTS OF LYSERGIDE].
    NAKAJIMA H; GRANDJEAN JL; LHUILLIER J; THUILLIER J
    Encephale; 1964; 53():SUPPL:131-41. PubMed ID: 14161525
    [No Abstract]   [Full Text] [Related]  

  • 13. Central action of adrenergic-blocking drugs.
    DOMER FR
    AFOSR TN United States Air Force Off Sci Res; 1961 Oct; AF61 052 469():1-21. PubMed ID: 24546945
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoamines and the regulation of vigilance and sleep.
    Putkonen PT
    Med Biol; 1974 Jun; 52(3):193-9. PubMed ID: 4370645
    [No Abstract]   [Full Text] [Related]  

  • 15. [PSYCHOPHARMACA: OBSERVATIONS AND INTERPRETATIONS].
    DESCHAEPDRYVER A
    Belg Tijdschr Geneesk; 1964 Dec; 20():1265-76. PubMed ID: 14261099
    [No Abstract]   [Full Text] [Related]  

  • 16. THE EFFECT OF L-3, 4-DIHYDROXYPHENYLALANINE AND DL-5-HYDROXYTRYPTOPHAN ON RIGIDITY AND TREMOR INDUCED BY RESERPINE, CHLORPROMAZINE AND PHENOXYBENZAMINE.
    ROOS BE; STEG G
    Life Sci (1962); 1964 Apr; 3():351-60. PubMed ID: 14172950
    [No Abstract]   [Full Text] [Related]  

  • 17. SPINAL REFLEXES AND MONOAMINE LIBERATION.
    ANDEN NE; JUKES MG; LUNDBERG A
    Nature; 1964 Jun; 202():1222-3. PubMed ID: 14217521
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.